The breast is an infrequently recognised site of primary giant cell arteritis. Two cases of giant cell arteritis affecting the breast are described and 11 previously described cases are reviewed. All cases presented with single or multiple breast masses, leading to a diagnosis before biopsy of suspected breast carcinoma. Symptoms similar to those of polymyalgia rheumatica occurred in about half of these patients, though the significance of these symptoms was only appreciated in retrospect. Clinical or pathological evidence of giant cell arteritis outside the breast (temporal artery, thyroid artery) was noted in a minority of cases. Seven patients received corticosteroid treatment, and all patients recovered without complications. Two patients had an adenocarcinoma of the breast contiguous with the giant cell arteritis.
The clinical picture of temporal arteritis has expanded considerably since 1932 when Bayard Horton et al described two patients with fever, weight loss, scalp tenderness, and temporal artery biopsies indicating arteritis. Since then 'temporal' arteritis has been described affecting the proximal aorta and all of its major arterial branches. Typically it affects subjects over the age of 50 and is usually associated with a raised erythrocyte sedimentation rate. The patient's headaches were relieved with prednisone.' None of these patients developed multisystem disease characteristic of Wegener's granulomatosis or polyarteritis nodosa during an average follow up period of 22'4 months (range five weeks to eight years). In all treated patients the size and tenderness of the breast masses, the sedimentation rate, and symptoms of polymyalgia rheumatica decreased over several weeks with tapering doses of prednisone. Four patients improved without corticosteroid treatment.' 4 9 11 In one case tender breast lumps and a raised sedimentation rate recurred when prednisone was discontinued after six months of treatment.' Giant cell arteritis of the breast cannot be easily differentiated clinically from carcinoma of the breast. The sudden onset of symptoms, absence of regional lymphadenopathy, and the presence of multifocal lesions in some cases should suggest the possibility of arteritis. Two reports of breast carcinoma and giant cell arteritis of the breast in contiguous segments of the same specimen, however, illustrate the importance of an excision biopsy.7 '0 Superficial thrombophlebitis of the breast-Mondor's disease-usually presents as tender subcutan-eous cords rather than ovoid masses.'8 At least two cases diagnosed as Mondor's disease had histological changes of resolving arteritis, however, including giant cells in one instance. 19 Wegener's granulomatosis is also a rare cause of granulomatous arteritis of the breast, coinciding with pulmonary disease.'3-6 Weber-Christian disease,20 fat necrosis,2' and sarcoidosis,22 23 are other rare causes of breast pain simulating a neoplasm. Unfortunately, the histology of giant cell arteritis is not sufficiently unique to differentiate it clearly from other forms of necrotising arteritis. The presence of giant cells is usual (10 of 13 cases in the table), but giant cells are seen in other forms of vasculitis and may be absent in otherwise typical cases of giant cell arteritis. The spectrum of acute to chronic vasculitis, illustrated by case 1, suggests that giant cell arteritis cannot be reliably differentiated from polyarteritis nodosa by histological criteria alone.
The breast is supplied mainly by two branches of the subclavian artery-the medial side by the internal mammary artery and the lateral aspect by the lateral thoracic artery (fig 3) . As giant cell arteritis has been described in all other major branches of the subclavian artery it is perhaps surprising that giant cell arteritis affecting the breast is not recognised more often. Symptoms and signs of giant cell arteritis caused by compromised blood flow-for example, blindness and claudication, might not be expected to produce symptoms in the richly vascularised breast. In fact the internal mammary artery flow can be completely diverted into the myocardium (Vineberg procedure) without deleterious effects. Because tender breast lumps are a common symptom of benign fibrocystic disease of the breast their occurrence may be underreported by patients and underinvestigated by doctors, unless the degree of inflammation is extraordinary. The fact that some breast lumps caused by giant cell arteritis are non-tender creates another possible source of underreporting.
Clinical examination of the breasts should be added to the standard evaluation of all women suspected of having polymyalgia rheumatica or giant cell arteritis, or both. Apart from the temporal arteries the breasts offer the only other reasonably accessible tissue for biopsy in suspected cases of giant cell arteritis. The rapid and sustained response to prednisone treatment and the importance of excluding more generalised forms of necrotising arteritis or carcinoma are compelling reasons to consider giant cell arteritis in the breast and carry out an excision biopsy.
